ESC 365 - The safety of apixaban compared to warfarin in hospitalized patients with acute kidney injury

Delegate Premium access

The safety of apixaban compared to warfarin in hospitalized patients with acute kidney injury

Session: Late-breaking science

Topic: Anticoagulants

Speaker: Doctor L. Alfehaid (Riyadh, SA)

Event: ESC Acute CardioVascular Care 2025

Congress Presentation

Add to my library

About the speaker

Doctor Lama Alfehaid

King Saud Bin Abdulaziz University for Health Sciences, Riyadh (Saudi Arabia)

1 presentation

0 follower

4 more presentations in this session

Diuretic treatment in acute heart failure with volume overload guided by serial spot urine sodium assessment

Speaker: Professor F. Verbrugge (Brussels, BE)

The influence of treatment delay on the benefit of a microaxial flow pump in patients with ST segment elevation myocardial infarction and cardiogenic shock

Speaker: Professor C. Hassager (Copenhagen, DK)

Performance of the BNP and NTproBNP triage algorithm for AHF including the effect of renal dysfunction

Speaker: Doctor D. Wussler (Basel, CH)

The Impella/mitral valve angle predicts early and late haemolysis in patients receiving Impella support

Speaker: Doctor V. Galusko (London, GB)

Access the full session

Late-breaking science

Speakers: Doctor L. Alfehaid, Professor F. Verbrugge, Professor C. Hassager, Doctor D. Wussler, Doctor V. Galusko

About the event

ESC Acute CardioVascular Care 2025

14 March - 15 March 2025

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources